Sweeney Michael E
Known title: ControllerCIK: 0001668475
Associated companies
Transaction History
| BCO | ▼ Sell | Open Market | 1,418 | $169K | 12/15/2025 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 612 | $72K | 9/30/2025 | View on chart |
| BCO | ▼ Sell | Open Market | 746 | $86K | 8/14/2025 | View on chart |
| BCO | ▼ Sell | Open Market | 795 | $87K | 8/13/2025 | View on chart |
| BCO | ▼ Sell | Open Market | 500 | $51K | 8/7/2025 | View on chart |
| BCO | ▼ Sell | Open Market | 500 | $53K | 8/7/2025 | View on chart |
| BCO | ▼ Sell | Open Market | 814 | $81K | 8/6/2025 | View on chart |
| BCO | ▼ Sell | Open Market | 500 | $49K | 8/6/2025 | View on chart |
| BCO | ▼ Sell | Open Market | 488 | $46K | 7/7/2025 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 227 | $20K | 3/3/2025 | View on chart |
| BCO | ▲ Buy | Grant | 1,298 | $0 | 3/3/2025 | View on chart |
| BCO | ▼ Sell | Other | 44 | — | 3/1/2025 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 206 | $19K | 3/1/2025 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 170 | $16K | 3/1/2025 | View on chart |
| BCO | ▼ Sell | Other | 53 | — | 3/1/2025 | View on chart |
| BCO | ▲ Buy | Grant | 3,404 | $322K | 2/19/2025 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 997 | $94K | 2/19/2025 | View on chart |
| BCO | ▼ Sell | Other | 332 | — | 2/19/2025 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 171 | $14K | 3/3/2024 | View on chart |
| BCO | ▼ Sell | Other | 54 | — | 3/1/2024 | View on chart |
| BCO | ▲ Buy | Grant | 1,392 | $0 | 3/1/2024 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 155 | $13K | 3/1/2024 | View on chart |
| BCO | ▼ Sell | Other | 37 | — | 2/24/2024 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 766 | $63K | 2/24/2024 | View on chart |
| BCO | ▼ Sell | Other | 227 | — | 2/24/2024 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 139 | $11K | 2/24/2024 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 415 | $34K | 12/3/2023 | View on chart |
| BCO | ▲ Buy | Grant | 1,694 | $0 | 3/3/2023 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 155 | $10K | 3/1/2023 | View on chart |
| BCO | ▼ Sell | Other | 54 | — | 3/1/2023 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 140 | $9K | 2/24/2023 | View on chart |
| BCO | ▼ Sell | Other | 37 | — | 2/24/2023 | View on chart |
| BCO | ▲ Buy | Grant | 2,544 | $0 | 2/16/2023 | View on chart |
| BCO | ▲ Buy | Grant | 2,030 | $0 | 9/22/2022 | View on chart |
| BCO | ▲ Buy | Grant | 1,683 | $0 | 3/1/2022 | View on chart |
| BCO | ▼ Sell | Tax Withholding | 140 | $10K | 2/24/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
Brink's Gets CMA Approval for NCR Atleos Deal Remedy
Brink's received acceptance in principle from the UK's CMA regarding a proposed remedy for its pending acquisition of NCR Atleos. The company also reported Q2 2026 results and confirmed that a potential sale of UK assets will not impact expected $200M in annual synergies. This regulatory progress is a key step in finalizing the transaction.
Brink's Gets CMA Approval for NCR Atleos Deal Remedy. Brink's received acceptance in principle from the UK's CMA regarding a proposed remedy for its pending acquisition of NCR Atleos. The company also reported Q2 2026 results and confirmed that a potential sale of UK assets will not impact expected $200M in annual synergies. This regulatory progress is a key step in finalizing the transaction.